• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌和胰腺癌中的18q21区域:DCC和DPC4表达的独立缺失

The 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expression.

作者信息

Barberá V M, Martín M, Mariñoso L, Munné A, Carrato A, Real F X, Fabre M

机构信息

Laboratorio de Oncologia Molecular y Celular, Universidad Miguel Hernández, Unidad de Investigación, Hospital Universitario de Elche, Alicante, Spain.

出版信息

Biochim Biophys Acta. 2000 Oct 18;1502(2):283-96. doi: 10.1016/s0925-4439(00)00054-5.

DOI:10.1016/s0925-4439(00)00054-5
PMID:11040453
Abstract

UNLABELLED

The 18q21 region is frequently altered in gastrointestinal tumors. Three candidate tumor suppressor genes have been identified in it: DCC, Smad4/DPC4 and Smad2; the mechanisms involving their inactivation have not been completely elucidated. In this study, genetic losses at 18q21 and expression of DCC and DPC4 in colorectal (n=12) and pancreatic (n=16) cell lines and in colorectal tissues (n=10) were analyzed. The status of the 18q21 region was assessed using microsatellite analysis and duplex PCR of exonic sequences; expression was analyzed by RT-PCR; mutational analysis of DPC4 cDNA was performed in selected cases. Homozygous losses of microsatellite markers at 18q21 were not observed in colon or pancreas lines; however, a higher proportion of apparent homozygosity than expected was found. DCC and DPC4 transcripts were detected in 11/12 and 12/12 colorectal cancer lines, respectively. In tumors, homozygous losses at 18q21 were detected in three cases, without affecting DCC. All tumors retained DCC and DPC4 mRNA expression. In pancreatic lines, DPC4 was inactivated through homozygous deletion (n=5), intragenic mutation (n=3), and lack of protein (n=2).

IN CONCLUSION

(1) microsatellite analysis does not provide adequate information regarding homozygous losses at 18q21; (2) approximately 65% of pancreas cancer lines show inactivation of DPC4; and (3) loss of DCC and DPC4 occur independently.

摘要

未标记

18q21区域在胃肠道肿瘤中经常发生改变。在该区域已鉴定出三个候选肿瘤抑制基因:DCC、Smad4/DPC4和Smad2;但其失活机制尚未完全阐明。在本研究中,分析了18q21区域的基因缺失以及DCC和DPC4在结肠(n = 12)和胰腺(n = 16)细胞系及结肠组织(n = 10)中的表达情况。使用微卫星分析和外显子序列的双重PCR评估18q21区域的状态;通过RT-PCR分析表达情况;对选定病例进行DPC4 cDNA的突变分析。在结肠或胰腺细胞系中未观察到18q21处微卫星标记的纯合缺失;然而,发现明显纯合性的比例高于预期。分别在11/12和12/12的结肠癌细胞系中检测到DCC和DPC4转录本。在肿瘤中,在三例中检测到18q21处的纯合缺失,但不影响DCC。所有肿瘤均保留DCC和DPC4 mRNA表达。在胰腺细胞系中,DPC4通过纯合缺失(n = 5)、基因内突变(n = 3)和缺乏蛋白(n = 2)而失活。

结论

(1)微卫星分析不能提供关于18q21处纯合缺失的充分信息;(2)约65%的胰腺癌细胞系显示DPC4失活;(3)DCC和DPC4的缺失是独立发生的。

相似文献

1
The 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expression.结直肠癌和胰腺癌中的18q21区域:DCC和DPC4表达的独立缺失
Biochim Biophys Acta. 2000 Oct 18;1502(2):283-96. doi: 10.1016/s0925-4439(00)00054-5.
2
Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.神经母细胞瘤中DCC、DPC4和MADR2/JV18-1基因的表达及突变分析
Cancer Res. 1997 Sep 1;57(17):3772-8.
3
Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.在一部分胰腺癌和胆管癌中,纯合缺失会使DCC失活,但不会使MADH4/DPC4/SMAD4失活。
Genes Chromosomes Cancer. 2000 Apr;27(4):353-7.
4
Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.晚期结直肠癌中DPC4/SMAD4基因双等位基因失活:日本患者肿瘤中七个新的体细胞突变的鉴定。
Mutat Res. 1999 Aug;406(2-4):71-7. doi: 10.1016/s1383-5726(99)00003-5.
5
SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.结直肠癌中的SMAD4突变可能发生在染色体不稳定之前,但在微卫星不稳定途径分歧之后。
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9719-23. doi: 10.1073/pnas.171321498. Epub 2001 Jul 31.
6
Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.克罗地亚患者散发性结肠腺癌中DPC4肿瘤抑制基因的状态:一种新型体细胞突变的鉴定。
Mutat Res. 2004 Apr 14;548(1-2):61-73. doi: 10.1016/j.mrfmmm.2003.12.018.
7
DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.人类结直肠癌和胰腺癌转移中的DCC和SMAD4改变。
Oncogene. 2000 Jan 27;19(4):546-55. doi: 10.1038/sj.onc.1203353.
8
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.DPC4,一种位于人类18号染色体q21.1区域的候选抑癌基因。
Science. 1996 Jan 19;271(5247):350-3. doi: 10.1126/science.271.5247.350.
9
Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas.与原发性胰腺腺癌相比,胰腺癌细胞系中DPC4/Smad4改变的频率更高。
Cancer Lett. 1999 May 3;139(1):43-9. doi: 10.1016/s0304-3835(98)00380-2.
10
Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.浆液性卵巢癌的等位基因分析显示,在18q22 - q23区域存在两个假定的肿瘤抑制基因座,位于SMAD4、SMAD2和DCC远端。
Am J Pathol. 2001 Jul;159(1):35-42. doi: 10.1016/S0002-9440(10)61670-7.

引用本文的文献

1
An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer.胰液中的 8q24 扩增是一种用于检测胰腺癌的候选生物标志物。
Int J Mol Sci. 2023 Mar 7;24(6):5097. doi: 10.3390/ijms24065097.
2
Reverse correlation of Jab1 and Smad4 in PANC-1 cells involved in the pathogenesis of pancreatic cancer.Jab1与Smad4在参与胰腺癌发病机制的PANC-1细胞中的反向相关性。
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9279-85. eCollection 2015.
3
Deletion and down-regulation of SMAD4 gene in colorectal cancers in a Chinese population.
中国人群结直肠癌中SMAD4基因的缺失与下调
Chin J Cancer Res. 2014 Oct;26(5):525-31. doi: 10.3978/j.issn.1000-9604.2014.09.02.
4
Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.利用 T22 增强的蛋白纳米颗粒靶向细胞内 CXCR4 ⁺ 细胞。
Int J Nanomedicine. 2012;7:4533-44. doi: 10.2147/IJN.S34450. Epub 2012 Aug 15.
5
Advances in biomarker research for pancreatic cancer.胰腺癌生物标志物研究进展。
Curr Pharm Des. 2012;18(17):2439-51. doi: 10.2174/13816128112092439.
6
Repeated anastomotic recurrence of colorectal tumors: genetic analysis of two cases.结直肠肿瘤吻合口复发的再发:两例病例的基因分析。
World J Gastroenterol. 2011 Aug 28;17(32):3752-8. doi: 10.3748/wjg.v17.i32.3752.
7
Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.炎症性肠病患者非发育异常黏膜中TP53、APC、K-ras和DCC基因的突变分析。
Int J Colorectal Dis. 2009 Oct;24(10):1141-8. doi: 10.1007/s00384-009-0748-5. Epub 2009 Jun 20.
8
Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells.蛋白酶体抑制剂MG-132对结肠癌细胞的抗有丝分裂作用需要骨形态发生蛋白信号传导。
Br J Pharmacol. 2008 Jun;154(3):632-8. doi: 10.1038/bjp.2008.115. Epub 2008 Apr 14.
9
Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells.缺失型胰腺癌相关基因4转染对人结肠癌细胞生物学行为的影响
World J Gastroenterol. 2005 Jan 21;11(3):348-52. doi: 10.3748/wjg.v11.i3.348.
10
Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer.早期结直肠癌中肿瘤抑制基因Smad4的罕见突变
Br J Cancer. 2003 Feb 10;88(3):420-3. doi: 10.1038/sj.bjc.6600733.